Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2018 March;43(1) > Minerva Endocrinologica 2018 March;43(1):69-79

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


eTOC

 

REVIEW  THE EVOLUTION OF IVF


Minerva Endocrinologica 2018 March;43(1):69-79

DOI: 10.23736/S0391-1977.17.02666-9

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Fertility preservation for social and oncofertility indications

Paul R. BREZINA 1, 2, 3

1 Reproductive Endocrinology and Infertility, Vanderbilt University School of Medicine, Nashville, TN, USA; 2 Department of Surgery St. Jude Children’s Research Hospital, Memphis, TN, USA; 3 Reproductive Genetics Fertility Associates of Memphis, Memphis, TN, USA


PDF  


The desire to reproduce is a base human instinct. However, for many individuals, the chances of being able to have a genetic child are compromised by a number of factors. For some, therapies aimed at treating serious medical illness, such as cancer; result in a deleterious impact on the function of eggs and sperm in the future thus compromising future fertility. In women, a predictable decrease in egg quality and quantity occurs with advancing maternal age. Therefore, women who choose to delay childbearing until their late 30s or early 40s may experience fertility difficulties that would not have been present earlier in life. Currently, technologies exist that allow individuals to have an “insurance policy” to preserve eggs or sperm prior to being exposed to agents, including time or specific toxic agents to the ovaries or sperm, that may decrease fertility potential. This article attempts to summarize the current state of the art technologies regarding fertility preservation for both social and oncofertility indications.


KEY WORDS: Fertility preservation - Cryopreservation - Freezing - Oocytes - Spermatozoa - Oncology

top of page

Publication History

Issue published online: January 11, 2018
Article first published online: May 8, 2017

Cite this article as

Brezina PR. Fertility preservation for social and oncofertility indications. Minerva Endocrinol 2018;43:69-79. DOI: 10.23736/S0391-1977.17.02666-9

Corresponding author e-mail

pbrezina@fertilitymemphis.com